Literature DB >> 22056131

Nodal/Activin signaling: a novel target for pancreatic cancer stem cell therapy.

Timothy R Donahue1, David W Dawson.   

Abstract

Targeting of cancer stem cells (CSCs) has the potential to address the recalcitrance of pancreatic cancer to chemotherapy. In this issue of Cell Stem Cell, Lonardo et al. (2011) demonstrate that Nodal/Activin signaling is crucial for the maintenance and tumor-initiating capacity of pancreatic CSCs. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Year:  2011        PMID： 22056131     DOI： 10.1016/j.stem.2011.10.006

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  3 in total

1.  Isolation of Lipid Raft Proteins from CD133+ Cancer Stem Cells.

Authors:  Vineet K Gupta; Sulagna Banerjee
Journal:  Methods Mol Biol       Date:  2017

Review 2.  Emerging frontiers in pancreatic cancer research: elaboration of key genes, cells and the extracellular milieu.

Authors:  Chandan Kumar-Sinha; Iris Wei; Diane M Simeone
Journal:  Curr Opin Gastroenterol       Date:  2012-09       Impact factor: 3.287

3.  Breast Cancer Stem Cells with Tumor- versus Metastasis-Initiating Capacities Are Modulated by TGFBR1 Inhibition.

Authors:  Flavia Fico; Mélanie Bousquenaud; Curzio Rüegg; Albert Santamaria-Martínez
Journal:  Stem Cell Reports       Date:  2019-06-27       Impact factor: 7.765
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.